Zobrazeno 1 - 10
of 41
pro vyhledávání: '"ACHROMOBACTER RUHLANDII"'
Publikováno v:
Microbiology Spectrum, Vol 11, Iss 4 (2023)
ABSTRACT Achromobacter is a genus of Gram-negative rods, which can cause persistent airway infections in people with cystic fibrosis (CF). The knowledge about virulence and clinical implications of Achromobacter is still limited, and it is not fully
Externí odkaz:
https://doaj.org/article/5c2c094dd8de4acdb9665d887e4703bd
Autor:
Chernukha M.Yu., Shaginyan I.A., Zhukhovitskiy V.G., Avetisyan L.R., Kulyastova D.G., Siyanova E.A., Medvedeva O.S., Polyakov N.B., Solovyov A.I., Grumov D.A., Kondratieva E.I., Kashirskaya N.Yu., Kapranov N.I., Sherman V.D., Voronkova A.Yu., Nikonova V.S., Amelina E.L., Krasovskiy S.A., Usachyova M.V.
Publikováno v:
Клиническая микробиология и антимикробная химиотерапия, Vol 19, Iss 4, Pp 327-334 (2017)
The objective of this study was to compare the MALDI Biotyper system and the microbiological diagnosis algorithm for identification of non-fermenting bacteria isolated from respiratory tract in cystic fibrosis patients. The identification and typing
Externí odkaz:
https://doaj.org/article/e408075b479c4f16948e2f5abba7add2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Denis Pierard, Julien Bador, Véronique Varin, Charlotte Peeters, Lucie Amoureux, Alexia Verroken, Arnaud Magallon, Nadia Makki, Lise Crémet, Angélique Chapuis, C. Neuwirth, Manon Dollat, Fedoua Echahidi, Emilie Cardot-Martin, Peter Vandamme, Elise Persyn, Thomas Garrigos
Publikováno v:
Journal of clinical microbiology, Vol. 59, no. 10, p. e0094621 [1-8] (2021)
J Clin Microbiol
JOURNAL OF CLINICAL MICROBIOLOGY
J Clin Microbiol
JOURNAL OF CLINICAL MICROBIOLOGY
Objective: Achromobacter spp. are increasingly reported among cystic fibrosis patients. Genotyping requires time consuming methods such as Multilocus-Sequence-Typing or Pulsed-Field-Gel-Electrophoresis. Therefore, data on the prevalence of the multir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58448aa95df43f1a7b8e89a9e2ee3288
https://hdl.handle.net/2078.1/259732
https://hdl.handle.net/2078.1/259732
Autor:
Helle Krogh Johansen, Jennifer A. Bartell, Migle Gabrielaite, Finn Cilius Nielsen, Rasmus L. Marvig, Tacjana Pressler, Niels Nørskov-Lauritsen
Publikováno v:
Gabrielaite, M, Bartell, J A, Nørskov-Lauritsen, N, Pressler, T, Nielsen, F C, Johansen, H K & Marviga, R L 2021, ' Transmission and Antibiotic Resistance of Achromobacter in Cystic Fibrosis ', Journal of Clinical Microbiology, vol. 59, no. 4, e02911-20 . https://doi.org/10.1128/JCM.02911-20
Achromobacter species are increasingly being detected in patients with cystic fibrosis (CF), and this emerging pathogen is associated with antibiotic resistance and more-severe disease outcomes. Nonetheless, little is known about the extent of transm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7291a857939eb58c338d4b006966c806
https://curis.ku.dk/ws/files/259102029/Journal_of_Clinical_Microbiology_2021_Gabrielaite_e02911_20.full.pdf
https://curis.ku.dk/ws/files/259102029/Journal_of_Clinical_Microbiology_2021_Gabrielaite_e02911_20.full.pdf
Publikováno v:
Antimicrob Agents Chemother
Achromobacter spp. are recognized as emerging pathogens in patients with cystic fibrosis (CF). Though recent works have established species-level identification using nrdA sequencing, there is a dearth in knowledge relating to species-level antimicro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bb77aece0baab57eebec0db6a3488d3
https://doi.org/10.1128/aac.01467-20
https://doi.org/10.1128/aac.01467-20
Autor:
Mauricio Langleib, Mariana Andrea Papalia, Gabriel Osvaldo Gutkind, Marcela Alejandra Radice, Carla Steffanowski, Maria Soledad Ramirez, Andrés Iriarte, Laura Galanternik, Vaughn S. Cooper
Publikováno v:
Revista Argentina de microbiologia. 54(1)
In the last decade Achromobacter spp. has been associated with chronic colonization in patients with cystic fibrosis (CF). Although Achromobacter xylosoxidans is the most frequent species recovered within this genus, other species such as A. ruhlandi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e14074cdec31916805d66bb83c7806ea
https://pubmed.ncbi.nlm.nih.gov/33896603
https://pubmed.ncbi.nlm.nih.gov/33896603
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Marcela Alejandra Radice, Carlos Vay, Maria Soledad Ramirez, Marisa Almuzara, German Matias Traglia, Mariana Andrea Papalia, Melina Ruggiero, Gabriel Osvaldo Gutkind
Publikováno v:
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Objectives: The aim of this study was to characterise OXA-258 variants and other features that may contribute to carbapenem resistance in Achromobacter ruhlandii. Methods: Kinetic parameters for purified OXA-258a and OXA-258b were determined measurin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::736ab9cb73fc19ac48c462432ef79ac3
https://www.sciencedirect.com/science/article/pii/S2213716518300675
https://www.sciencedirect.com/science/article/pii/S2213716518300675